OTCPK:MCDA

Stock Analysis Report

Executive Summary

KMA Holding, Inc., through its subsidiaries, manufactures human and pet home medical test kits and emergency response mobile hospital units in the United States.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • KMA Holding has significant price volatility in the past 3 months.
  • KMA Holding's last earnings update was 2992 days ago.
  • KMA Holding is not covered by any analysts.

Share Price & News

How has KMA Holding's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

23.1%

MCDA

0.7%

US Medical Equipment

-0.2%

US Market


1 Year Return

n/a

MCDA

9.5%

US Medical Equipment

1.1%

US Market

No trading data on MCDA.

No trading data on MCDA.


Share holder returns

MCDAIndustryMarket
7 Day23.1%0.7%-0.2%
30 Day-50.0%0.1%2.5%
90 Dayn/a2.5%1.6%
1 Yearn/a10.4%9.5%3.4%1.1%
3 Yearn/a69.3%64.1%45.2%35.8%
5 Yearn/a138.0%110.9%62.6%44.8%

Price Volatility Vs. Market

How volatile is KMA Holding's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is KMA Holding undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether KMA Holding is trading at an attractive price based on the cash flow it is expected to produce in the future. But as KMA Holding has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine KMA Holding's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through KMA Holding regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is KMA Holding expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as KMA Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has KMA Holding performed over the past 5 years?

0.2%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, KMA Holding has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is KMA Holding's financial position?


In this section we usually analyse KMA Holding's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. KMA Holding has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of MCDA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when KMA Holding's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is KMA Holding's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate KMA Holding's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate KMA Holding's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as KMA Holding has not reported any payouts.

Unable to verify if KMA Holding's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as KMA Holding has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of KMA Holding's salary, the management and board of directors tenure and is there insider trading?

10.9yrs

Average management tenure


CEO

Ron Ritter 0

0yrs

Tenure

0

Mr. Ronald Ritter, Ron serves as the Chairman and Chief Executive Officer of KMA Holding, Inc. Mr. Ritter has been in management for over 30 years. He has run single as well as multiple locations with annu ...


Management Age and Tenure

10.9yrs

Average Tenure

The average tenure for the KMA Holding management team is over 5 years, this suggests they are a seasoned and experienced team.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Anthony Mellone

    Consultant and Director

    • Tenure: 0yrs
  • Geoffrey Grosso

    President of Rapid Fitness Franchise

    • Tenure: 12.1yrs
  • Marckensie Theresias (43yo)

    Executive Vice President and Director

    • Tenure: 0yrs
  • J. Hollingshead

    Chief Operating Officer

    • Tenure: 10.9yrs
  • Charles Ilvento

    Chief Financial Officer

    • Tenure: 10.9yrs
  • Scott Spooner

    Chief Geologist

    • Tenure: 10.9yrs
  • Ron Ritter

    Chairman and Chief Executive Officer

    • Tenure: 0yrs

Board Members

  • Anthony Mellone

    Consultant and Director

    • Tenure: 0yrs
  • Donna Yamin

    Director

    • Tenure: 0yrs
  • Marckensie Theresias (43yo)

    Executive Vice President and Director

    • Tenure: 0yrs
  • Ron Ritter

    Chairman and Chief Executive Officer

    • Tenure: 0yrs

Company Information

KMA Holding, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: KMA Holding, Inc.
  • Ticker: MCDA
  • Exchange: OTCPK
  • Founded: 2000
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$339.201m
  • Shares outstanding: 42.40b
  • Website: https://null

Location

  • KMA Holding, Inc.
  • 4701 North Federal Highway
  • Suite 430
  • Pompano Beach
  • Florida
  • 33064
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MCDAOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJun 2003

Biography

KMA Holding, Inc., through its subsidiaries, manufactures human and pet home medical test kits and emergency response mobile hospital units in the United States. The company focuses on the detection of var ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 00:45
End of Day Share Price2019/09/17 00:00
Earnings2011/06/30
Annual Earnings2010/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.